We are live on
!
Find out more
CH
CVI Holdings Portfolio holdings
AUM
$116M
1-Year Est. Return
5.68%
This Fund
S&P 500
This Quarter
Est. Return
-1.49%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
-$139M
(-9.2%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.62%
Top 10 Holdings %
Top 10 Hldgs %
10.8%
Holding
1,026
New
99
Increased
30
Reduced
127
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seres Therapeutics
MCRB
|
+$11.7M |
| 2 |
Precision BioSciences
DTIL
|
+$8.32M |
| 3 |
DHAI
DIH Holdings US
DHAI
|
+$7.92M |
| 4 |
GBBK
Global Blockchain Acquisition Corp. Common Stock
GBBK
|
+$6.13M |
| 5 |
FGMC
FG Merger Corp. Common Stock
FGMC
|
+$5.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SV
Spring Valley Acquisition Corp. Class A Ordinary Share
SV
|
+$18.3M |
| 2 |
Bank of Montreal
BMO
|
+$12.2M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$9.41M |
| 4 |
MACU
Mallard Acquisition Corp. Common stock
MACU
|
+$9.08M |
| 5 |
TCAC
Tuatara Capital Acquisition Corporation Class A Ordinary Shares
TCAC
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 67.24% |
| 2 | Technology | 9.48% |
| 3 | Healthcare | 9.22% |
| 4 | Industrials | 4.19% |
| 5 | Consumer Discretionary | 2.82% |
Similar funds
EL
YSP
GIM
FWM
CPG
WCM
ETIA
RCM
CVI Holdings's Q2 2022 Portfolio in Review
As of Q2 2022, CVI Holdings held 1,026 positions worth $1.38B, down 9.2% from $1.51B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
CVI Holdings withdrew a net $105M in Q2 2022, closing 96 positions and reducing 127 holdings. Its most notable exit was Spring Valley Acquisition Corp. Class A Ordinary Share, an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Financials at 67% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.
Against the trend, CVI Holdings opened a new position in Seres Therapeutics worth $9.34M.
- CVI Holdings's largest Q2 2022 buy was Seres Therapeutics: 136,141 shares worth $9.34M.
- CVI Holdings added most to Ares Acquisition Corporation in Q2 2022, an estimated $2.45M increase.
- CVI Holdings's biggest Q2 2022 reduction was 2seventy bio, cutting an estimated $9.41M.
- CVI Holdings fully exited Spring Valley Acquisition Corp. Class A Ordinary Share in Q2 2022, selling an estimated $18.3M.
- CVI Holdings's ten largest holdings make up 11% of its $1.38B portfolio in Q2 2022.
- CVI Holdings opened 99 new positions and closed 96 in Q2 2022.
- CVI Holdings's portfolio value fell 9.2% quarter-over-quarter to $1.38B.
Based on CVI Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.